ISRAEL
(State or other jurisdiction of Incorporation or Organization) |
Not Applicable
(I.R.S. Employer Identification Number) |
Copy to:
Joshua G. Kiernan
Latham & Watkins LLP
99 Bishopsgate
London EC2M 3XF
United Kingdom
+44 20 7710 1000
|
David S. Glatt, Adv.
Jonathan M. Nathan, Adv.
Meitar Liquornik Geva Leshem Tal
16 Abba Hillel Silver Rd.
Ramat Gan 5250608, Israel
Tel: +972 (3) 610-3100
Fax: +972 (3) 610-3111
|
Large accelerated filer ☐
|
|
|
Accelerated filer ☒
|
|
Non-accelerated filer ☐
Emerging Growth Company ☐
|
|
|
Smaller reporting company ☐
|
|
Title of Each Class of Securities to be Registered
|
Amount to be Registered(1)
|
Proposed Maximum Offering Price per Unit
|
Proposed Maximum Aggregate Offering Price
|
Amount of Registration Fee
|
||||||||||||
Ordinary Shares, par value NIS 0.01 per share
|
544,055(2
|
)
|
$
|
3.01
|
(3)
|
$
|
1,637,605.55
|
(3)
|
$
|
212.56
|
(1) |
In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from
stock splits, stock dividends or similar transactions.
|
(2) |
Consists of an additional 544,055 shares issuable under the MediWound Ltd. 2014 Equity Incentive Plan, as amended (the “2014 Plan”).
|
(3) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant’s Ordinary
Shares as reported on The Nasdaq Global Market on February 19, 2020.
|
Exhibit Number
|
Description
|
|
(1) |
Filed as Exhibit 1.1 on February 25, 2020 pursuant to a registration statement on Form 20-F (File No. 333-36349) and incorporated by reference herein.
|
(2) |
Filed as Exhibit 3.3 on March 3, 2014 pursuant to a registration statement on Form F-1 (File No. 333-193856) and incorporated by reference herein.
|
(3) |
Filed as Exhibit 4.9 on February 25, 2020 pursuant to a registration statement on Form F-20 (File No. 333-36349) and incorporated by reference herein.
|
|
MEDIWOUND LTD.
By: /s/ Sharon Malka
Name: Sharon Malka
Title: Chief Executive Office
|
Signature
|
Title
|
Date
|
||
/s/ Sharon Malka
|
Chief Executive Officer
|
February 25, 2020
|
||
Sharon Malka
|
(Principal Executive Officer)
|
|||
/s/ Boaz Gur-Lavie
|
Chief Financial Officer
|
February 25, 2020
|
||
Boaz Gur-Lavie
|
(Principal Financial and Accounting Officer)
|
|||
/s/ Stephen T. Wills
|
Active Chairman of the Board and Director
|
February 25, 2020
|
||
Stephen T. Wills
|
|
|||
/s/ Ofer Gonen
|
Director
|
February 25, 2020
|
||
Ofer Gonen
|
|
|||
/s/ Vickie R. Driver
|
Director
|
February 25, 2020
|
||
Vickie R. Driver
|
|
|||
/s/ Nissim Mashiach
|
Director
|
February 25, 2020
|
||
Nissim Mashiach
|
|
|||
/s/ Sharon Kochan
|
Director
|
February 25, 2020
|
||
Sharon Kochan
|
|
|||
/s/ Assaf Segal
|
Director
|
February 25, 2020
|
||
Assaf Segal
|
|
|||
PUGLISI & ASSOCIATES
|
Authorized Representative in the United States
|
February 25, 2020
|
Very truly yours,
|
|
/s/ Meitar | Law Offices
Meitar | Law Offices
|
Tel Aviv, Israel
February 25, 2020
|
/s/ KOST, FORER, GABBAY & KASIERER
A Member of Ernst & Young Global
|